A Phase IV Study of Teneligliptin (MP-513) in Combination With Insulin in Japanese Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Teneligliptin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 07 Jun 2017 Biomarkers information updated
- 08 May 2016 Status changed from active, no longer recruiting to completed.
- 23 Jul 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.